Abstract
The pulmonary surfactants are considered predominantly from the perspective of surfactant insufficiency in preterm newborns developing respiratory distress syndrome (RDS). Currently, lung extracts of animal origin, known as therapeutic pulmonary surfactants, are largely used in RDS treatment. We introduced a new in vitro method for the study of therapeutic pulmonary surfactants based on the model black foam film, including bilayer film. Microscopic foam films from aqueous surfactant solutions are explored by means of interferometric technique which provides for introducing new parameters and measuring new dependences characterising interfacial properties of therapeutic pulmonary surfactants. Film thickness, probability of black film formation and disjoining pressure are measured. The wetting properties of surfactant solutions are studied. Interfacial characteristics such as minimal surfactant concentration to obtain black film and concentration at which a black film is 100% obtained are determined. The following therapeutic pulmonary surfactants are studied: Curosurf, Infasurf, Survanta, Alveofac and Exosurf.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Colloid and Interface Science in Pharmaceutical Research and Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
